Payment & Shipping Terms:
668270 12 0,
274693 27 5
Linagliptin CAS : 668270-12-0 GMP DMF
Name : Linagliptin
CAS No . : 668270-12-0
Chemical Name : 8 - [ ( 3R ) - 3 - Aminopiperidin - 1 -yl ] - 7 - ( but - 2 - yn - 1 - yl ) - 3 - methyl - 1 - [ ( 4 - methylquinazolin - 2 - yl ) methyl ] - 3 , 7 - dihydro - 1H - purine - 2 , 6 - dione
Molecular Formula : C25H28N8O2
Molecular Weight : 472.54
Linagliptin is the active pharmaceutical ingredient (API) of branded drug Tradjenta, Trajenta or Trazenta. It was innovated by the Germany drug maker Boehringer Ingelheim and cooperated the marketing with Lily. Linagliptin was approve by the US FDA in 2011. Linagliptin is used for the treatment of type 2 diabetes. Linagliptinis is a Dipeptidyl peptidase-4 inhibitor (DPP-4, DPP-IV).
The drug might be protected by patents in some courtires or areas. We only sell it to non patent protected countries or areas. The sale to patent protection countries and areas is only for R & D purpose. The buyers should take all responsiblity of patent status in his countries or areas.
Competitive Advantage: Produced under cGMP conditions, support customers’ registrations.